U.S. Markets open in 6 hrs 43 mins

Omeros Corporation (OMER)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.81-0.26 (-1.62%)
At close: 4:00PM EDT
People also watch
TGTXFOLDSGYPPETXOMED
Interactive chart
Previous Close16.07
Open15.91
Bid10.70 x 200
Ask16.65 x 100
Day's Range15.56 - 16.13
52 Week Range7.20 - 17.19
Volume369,123
Avg. Volume655,003
Market Cap694.68M
Beta4.13
PE Ratio (TTM)-10.78
EPS (TTM)-1.47
Earnings DateAug 7, 2017 - Aug 11, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est36.67
Trade prices are not sourced from all markets
  • Capital Cube13 hours ago

    ETFs with exposure to Omeros Corp. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Omeros Corp. Here are 5 ETFs with the largest exposure to OMER-US. Comparing the performance and risk of Omeros Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Omeros Corp. :OMER-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
    Capital Cube4 days ago

    Omeros Corp. :OMER-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017

    Categories: Yahoo FinanceGet free summary analysis Omeros Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Omeros Corp. – Pfizer Inc., BioTime, Inc., Johnson & Johnson, Acura Pharmaceuticals, Inc., Akorn, Inc., DURECT Corporation and Pain Therapeutics, Inc. (PFE-US, BTX-US, JNJ-US, ACUR-US, AKRX-US, DRRX-US and PTIE-US) ... Read more (Read more...)

  • Accesswire5 days ago

    Blog Coverage: Omeros' Stock Jumped on Completion of IgA nephropathy Cohort and Additional Positive Results

    Upcoming AWS Coverage on Halozyme Therapeutics Post-Earnings Results LONDON, UK / ACCESSWIRE / May 18, 2017 / Active Wall St. blog coverage looks at the headline from Omeros Corp. (NASDAQ: OMER ) as the ...